It also reviews the results of the various interventions to facilitate the surgeon in choosing the appropriate treatment option for any given patient. Degenerative spondylolisthesis is believed to ...
The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance to a standalone lateral lumbar interbody fusion device from the internationally renowned surgeon Randal Betz, M.D.’s company, ...
as a treatment for degenerative disc disease (DDD) with up to grade 1 spondylolisthesis. This also marks the second FDA ...